SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-05-006205
Filing Date
2005-02-14
Accepted
2005-02-14 13:11:11
Documents
1
Group Members
CITADEL DERIVATIVES GROUP LLCCITADEL INVESTMENT GROUP, L.L.C.CITADEL WELLINGTON LLCKENNETH GRIFFIN

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a05-2886_23sc13ga.htm SC 13G/A 207563
  Complete submission text file 0001104659-05-006205.txt   209836
Mailing Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317
Business Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317 724-514-1800
MYLAN LABORATORIES INC (Subject) CIK: 0000069499 (see all company filings)

IRS No.: 251211621 | State of Incorp.: PA | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-10728 | Film No.: 05606374
SIC: 2834 Pharmaceutical Preparations

Mailing Address 131 S. DEARBORN STREET, 32ND FLOOR CHICAGO IL 60603
Business Address 131 S. DEARBORN STREET, 32ND FLOOR CHICAGO IL 60606 3123952100
CITADEL L P (Filed by) CIK: 0001027745 (see all company filings)

IRS No.: 364111741 | State of Incorp.: IL | Fiscal Year End: 1231
Type: SC 13G/A